tiprankstipranks
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
US Market
XERS
Xeris Pharmaceuticals
RESEARCH TOOLSreports

Xeris Pharmaceuticals (XERS) Income Statement

1,097 Followers

Xeris Pharmaceuticals Income Statement

Last quarter (Q4 2025), Xeris Pharmaceuticals's total revenue was $85.81M, an increase of 42.78% from the same quarter last year. In Q4, Xeris Pharmaceuticals's net income was $11.08M. See Xeris Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 291.85M$ 203.07M$ 163.91M$ 110.25M$ 49.59M
Gross Profit
$ 238.43M$ 166.24M$ 135.27M$ 87.61M$ 36.27M
Operating Expenses
$ 213.54M$ 199.88M$ 179.28M$ 169.55M$ 151.43M
Depreciation and Amortization
$ 12.16M$ 12.63M$ 13.16M$ 12.67M$ 1.88M
EBITDA
$ 12.71M$ -13.99M$ -23.73M$ -69.31M$ -113.67M
Operating Income
$ 24.90M$ -33.65M$ -44.01M$ -81.94M$ -115.16M
Other Income/Expenses
$ -24.34M$ -23.46M$ -19.49M$ -14.14M$ -7.57M
Pretax Income
$ 554.00K$ -57.10M$ -63.50M$ -96.08M$ -122.72M
Net Income
$ 554.00K$ -54.84M$ -62.26M$ -94.66M$ -122.72M
Per Share Metrics
Basic EPS
$ <0.01$ -0.37$ -0.45$ -0.70$ -1.55
Diluted EPS
$ <0.01$ -0.37$ -0.45$ -0.70$ -1.55
Weighted Average Shares Outstanding
 160.43M 146.77M 137.67M 135.63M 79.03M
Weighted Average Shares Outstanding (Diluted)
 172.74M 146.77M 137.67M 135.63M 79.03M
Currency in USD

Xeris Pharmaceuticals Earnings and Revenue History